Haiyan Xing
Chinese Academy of Medical Sciences & Peking Union Medical College(CN)People's Hospital of Xinjiang Uygur Autonomous Region(CN)National Clinical Research(US)Institute of Hematology & Blood Diseases Hospital(CN)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, CAR-T cell therapy research, Immune Cell Function and Interaction, Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → 2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies(2019)185 cited
- → Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells(2018)107 cited
- → CD33-Specific Chimeric Antigen Receptor T Cells with Different Co-Stimulators Showed Potent Anti-Leukemia Efficacy and Different Phenotype(2018)95 cited
- → RPS27a promotes proliferation, regulates cell cycle progression and inhibits apoptosis of leukemia cells(2014)74 cited
- → TBLR1 fuses to retinoid acid receptor α in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia(2014)66 cited
- → Regulatory T cells promote the stemness of leukemia stem cells through IL10 cytokine-related signaling pathway(2021)62 cited